Dezhan Healthcare Company Limited

Sümbol: 000813.SZ

SHZ

2.97

CNY

Turuhind täna

94.4346
P/E suhe
5.6661
PEG suhe
6.43B
MRK Cap
0.00%
DIV tootlus

Dezhan Healthcare Company Limited (000813-SZ) Finantsaruanded

Q: Mis on Dezhan Healthcare Company Limited (000813.SZ) koguvara?

Dezhan Healthcare Company Limited (000813.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Dezhan Healthcare Company Limited (000813.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 672.385 M, mis on 0.048 % gowth. Kogu perioodi keskmine brutokasum on 393.696 M, mis on 0.457 %. Keskmine brutokasumi suhtarv on 0.370 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -1.543 %, mis on võrdne 0.638 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Dezhan Healthcare Company Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.052. Käibevara valdkonnas on 000813.SZ aruandlusvaluutas 3539.033. Märkimisväärne osa neist varadest, täpsemalt 2796.417, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.076%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 551.443, kui neid on, aruandlusvaluutas. See näitab erinevust 0.586% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 4.635 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.165%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 5237.903 aruandlusvaluutas. Selle aspekti aastane muutus on -0.010%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 529.54, varude hind on 207.56 ja firmaväärtus 289.71, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 185.28.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	11327.27	2796.4	2599.1	1892.1	3514.4	3573.7	1444.7	1924.4	1685.6	148.6	150	52.2	46.6	148.3	192.2	141.7	77.7	69.4	91.9	96.7	107.6	156.8	155.3	178.6	232.2	110.8	113	67.6	47.9	70.3
balance-sheet.row.short-term-investments	-55.14	-16.7	400	418.4	1100.9	2092	402.5	0	0	-5.7	0	0	0	0	0	0	0	0	0	0.1	0.2	54.4	33.3	56.9	140.5	0	27	0	0	0
balance-sheet.row.net-receivables	2139.26	529.5	702.9	720.5	901.3	1060.7	2472.6	1997.1	1221.2	28.8	52.8	61.6	68.7	73.4	97	74.1	94.8	107.4	104.8	89	159.5	200.6	213.5	184	25.6	65.2	266.6	299.4	179.9	208.9
balance-sheet.row.inventory	862.68	207.6	250.9	300	313	331.7	286.4	231.6	182.6	183.7	235.9	253.9	240	238.3	196.2	139.9	203	243.2	210.7	221	268.9	322.9	442.6	473.5	476.2	402.3	424.7	465.2	450.2	377.2
balance-sheet.row.other-current-assets	40.01	5.5	404.9	650.1	70.8	45.2	554.8	287.2	232.4	5.3	5.9	1.1	0.2	0.2	0.2	0.2	0.3	0.2	-10.8	-14.9	-30.2	-30.8	0.1	-31.8	252.8	218.5	2.2	-44.3	0.1	-0.1
balance-sheet.row.total-current-assets	14369.22	3539	3957.8	3562.8	4799.4	5011.2	4758.4	4440.2	3321.9	366.4	444.7	368.9	355.4	460.2	485.6	355.9	375.8	420.2	396.6	391.9	505.9	649.5	811.4	804.4	986.8	796.8	806.6	787.9	678.1	656.3
balance-sheet.row.property-plant-equipment-net	3047.37	784.7	708.6	707.2	664.4	608.9	609.7	596.8	500.5	738.9	710.5	638.4	178.3	145.9	137.3	143.3	154.3	161.2	173.9	196.9	213	231.7	249.1	252	272.1	285.8	262.4	269.4	242.8	252
balance-sheet.row.goodwill	1067.45	289.7	198.3	198.3	212.5	23.1	23.1	23.1	23.1	23.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	826.17	185.3	214.9	285	196.9	50.2	56.2	62.4	66.3	837	850	872.8	57.4	58.7	11.3	11.7	4.6	4.8	4.8	5	5.2	4.9	5.1	5.2	5	5.1	5.2	5.4	7.4	7.6
balance-sheet.row.goodwill-and-intangible-assets	1893.61	475	413.2	483.3	409.4	73.4	79.3	85.5	89.4	837	850	872.8	57.4	58.7	11.3	11.7	4.6	4.8	4.8	5	5.2	4.9	5.1	5.2	5	5.1	5.2	5.4	7.4	7.6
balance-sheet.row.long-term-investments	2156.89	551.4	548.2	143.7	-640.6	-1940.6	0	0	0	18.2	15.2	0	0	0	0	0	0	0	0	2.4	2.4	113.1	123.2	95.9	-49.2	0	23.1	0	0	0
balance-sheet.row.tax-assets	80.81	15	22.9	31.1	49.7	64.3	65.8	12.9	11.3	1.8	6.2	4.4	2.7	2.9	3.5	3.6	2.8	2.7	0	0	0	55.9	35	59.3	142	0	29.5	0	0	0
balance-sheet.row.other-non-current-assets	65.94	13.4	23.6	850	1117.1	2110.6	408.4	3.6	3.8	10	5.2	15.9	0.9	1.2	1.6	1.9	4.3	2.1	2.7	1.2	1.4	0.3	0.3	0.4	0.6	58	1.4	24.6	28.2	29.4
balance-sheet.row.total-non-current-assets	7244.63	1839.6	1716.6	2215.3	1600	916.6	1163.2	698.8	605.1	1605.8	1587.1	1531.6	239.3	208.6	153.7	160.4	166	170.7	181.4	205.4	222	405.9	412.7	412.8	370.5	348.9	321.6	299.4	278.4	289
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	21613.85	5378.6	5674.4	5778	6399.4	5927.8	5921.6	5139	3926.9	1972.3	2031.7	1900.5	594.7	668.8	639.3	516.3	541.7	590.9	578	597.3	727.8	1055.5	1224.2	1217.2	1357.3	1145.7	1128.3	1087.3	956.5	945.3
balance-sheet.row.account-payables	294.85	26.3	140.8	31.3	53.6	33	57	76.6	57.6	57.8	56.7	62.4	27.8	24.8	20.5	11.2	26.6	35.6	31.9	17	15.8	59.1	55.6	71.5	56.2	52.8	16.7	60.1	53.4	88.6
balance-sheet.row.short-term-debt	10.15	2.9	2.2	5.3	45.8	-22.6	1.3	0.4	0.4	333.4	255.9	113	81.1	181.4	160.5	40.7	2.1	44	50.3	183	311.9	395.2	323.6	325	461.4	278.2	273.8	462.9	401.5	342.8
balance-sheet.row.tax-payables	25.16	3.4	8	6.7	2.3	5.1	54.1	98.7	47.2	21.8	41.5	27.8	-1.9	-1.4	-3	4.4	-1.5	0.3	2.1	5.9	2.6	9.6	3	-5.6	-3.2	2.9	22.5	2.2	-12	3.8
balance-sheet.row.long-term-debt-total	21.22	4.6	6.9	7.1	11.1	5	5	63.4	0	119.8	123.1	203.9	34.4	0	0	0	0	0	0	0	15	27	60	101.8	90	30	30	30	8.2	2.4
Deferred Revenue Non Current	31.4	7.6	9.3	11.1	10.8	12.4	11.3	13.1	12.4	24.2	19.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	85.77	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	91.99	0	163.6	0.2	286.3	265.7	565.5	498	1.6	21.6	46.2	31.4	10.4	12.9	12.8	14.3	17.6	11.2	20.6	19.7	19.4	27.4	11.5	2.3	2.5	1.2	15.5	40.1	0.9	0.1
balance-sheet.row.total-non-current-liabilities	158.39	39.9	55.6	57.9	33.3	17.4	16.4	18.6	18	116.6	240.9	224.1	41.2	2.7	1.1	0.9	0.6	8.5	0.1	12.1	15.2	27	60	101.8	87.5	40.1	37.5	45.3	19.2	18.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-12.1	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	21.22	4.6	6.9	7.1	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	853.53	137.1	390.4	308.1	446.4	316.2	640.2	593.6	175.4	599.4	679.7	490.5	179.5	239.9	214	92.7	63.1	120.9	127.1	270.1	431.7	583	547.4	566.7	707.2	506.2	515.4	752	663.8	661.9
balance-sheet.row.preferred-stock	0	0	0	8.3	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3484.86	869.1	930.5	945.6	945.6	945.6	945.6	945.6	198.4	467.5	467.5	467.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	363.5	338.1	338.1	187.8	140.8	253	253
balance-sheet.row.retained-earnings	15603.22	3934	3847.6	3894.5	4420.9	4136.4	3799.5	2868.9	2071.8	-524.6	-530.8	-450.3	-529.1	-515.5	-519	-525.3	-477.5	-481.1	-498	-510.6	-520.5	-347	-142.2	-147	32.6	24.6	96.2	42.8	2.4	1.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	952.22	46.6	0.3	-8.3	-8.3	48.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	759.37	388.3	514.3	532	530.9	482.2	536.4	730.9	1483.1	1121.1	1120.3	1120.1	567.3	567.3	567.4	568	568.7	568.6	568.7	456.9	430.4	427.5	428.2	427.5	274.6	272.8	323.6	147.3	32.7	23.1
balance-sheet.row.total-stockholders-equity	20799.67	5237.9	5292.6	5372.1	5897.4	5612.9	5281.5	4545.4	3753.3	1063.9	1057	1137.3	401.7	415.2	411.9	406.1	454.6	451	434.2	309.8	273.3	443.9	649.5	643.9	645.2	635.5	607.6	330.9	288.1	277.9
balance-sheet.row.total-liabilities-and-stockholders-equity	21613.85	5378.6	5674.4	5778	6399.4	5927.8	5921.6	5139	3926.9	1972.3	2031.7	1900.5	594.7	668.8	639.3	516.3	541.7	590.9	578	597.3	727.8	1055.5	1224.2	1217.2	1357.3	1146.7	1128.3	1087.3	956.5	945.3
balance-sheet.row.minority-interest	-39.35	3.6	-8.6	97.9	55.7	-1.2	0	0	-1.7	308.9	295	272.8	13.5	13.7	13.4	17.5	24	19	16.8	17.4	22.8	28.6	27.3	6.6	4.9	5	5.2	4.4	4.6	5.4
balance-sheet.row.total-equity	20760.32	5241.5	5284	5470	5953.1	5611.6	5281.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	21613.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	2101.75	534.7	548.2	562.1	460.3	151.4	402.5	2.5	2.5	12.5	15.2	0	0	0	0	0	0	1.4	1.8	2.5	2.6	167.5	156.6	152.7	91.3	55	50.1	0	0	0
balance-sheet.row.total-debt	31.37	7.6	9.1	12.4	56.9	5	6.3	0.4	0.4	333.4	378.9	316.9	115.5	181.4	160.5	40.7	2.1	44	50.3	183	326.9	422.2	383.6	426.7	551.4	308.2	303.8	492.9	409.7	342.8
balance-sheet.row.net-debt	-11295.89	-2788.8	-2590.1	-1461.4	-2356.5	-1476.7	-1438.4	-1924.1	-1685.2	184.8	228.9	264.6	68.9	33.1	-31.7	-101	-75.6	-25.4	-41.7	86.5	219.5	319.8	261.6	305	459.7	197.3	217.8	425.2	361.8	272.6

Rahavoogude aruanne

Dezhan Healthcare Company Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -1.338 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab -6.603 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 178022406.000. See on -0.824 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 83.67, -51.9, -0.86, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -0.03 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -160.94, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	64.65	54.2	-153.4	-96.2	273.6	335.7	930.5	795.3	659.2	30.1	51.3	76.9	-13.8	3.9	5.5	-50.1	2.2	15.4	12.7	9.9	-179.1	-204.4	4	-145.5	19	69.8	67.2
cash-flows.row.depreciation-and-amortization	5.39	83.7	94.7	84.5	68.6	52.2	45.1	24.9	20.5	42.6	56.2	45.7	9.6	9.9	9.3	10.2	12.9	14.6	15.9	16.7	17.8	25.5	19	18.8	20.8	21.8	21.1
cash-flows.row.deferred-income-tax	0	12.3	7	20.5	13.6	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-12.3	-7	-20.5	-13.6	-1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	86.18	29.2	80.1	-108.9	575.4	1192.5	-594.3	-436.8	-430.4	12.5	-32.7	10.1	8.5	-48.2	-79.4	50.4	24	-33.1	-6.8	100.7	28.3	99.5	17.3	-24.4	-101.4	-62.5	-26.4
cash-flows.row.account-receivables	21.15	168.7	9.3	19.9	473.8	1968.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	65.03	130.8	-22.3	35.6	20.1	-84.9	-54.8	-48.9	-39.4	64.7	-9.7	-10.7	-5.3	-43.4	-53.7	69.1	51.2	-36.7	18.3	49.6	51.7	83.8	63.2	-31.8	-67.4	0.7	40.5
cash-flows.row.account-payables	0	-282.6	86.1	-184.9	67.9	-692.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	12.3	7	20.5	13.6	1.4	-539.5	-387.9	-391	-52.2	-23	20.8	13.8	-4.8	-25.7	-18.7	-27.2	3.6	-25.1	51.2	-23.4	15.6	-45.8	7.4	-34	-63.2	-66.9
cash-flows.row.other-non-cash-items	-55.49	-39.2	140.4	163	-90	-21.6	-1.5	1.2	13.1	39.8	61.7	37.9	12.2	16.9	24.3	25.5	17.4	-3.8	0.8	7.5	177.7	73.5	-8.3	83.1	20.4	24.1	39.1
cash-flows.row.net-cash-provided-by-operating-activities	100.73	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-166.78	-159.7	-67.6	-126.9	-110.3	-65.1	-68.6	-112	-75	-61.9	-81	-85.2	-44.7	-44.7	-28.1	-10.3	-8.2	-4.2	-1.2	-1	-13.2	-7.9	-20.1	-20	-8.1	-35.9	-15.5
cash-flows.row.acquisitions-net	-62.25	-10.4	1.5	0.1	-276.9	0.1	0	0	0	0	0.1	85.2	0	8.5	3.6	1.1	0	5.3	0	0	15.2	12.1	20.1	20.2	0.7	35.9	18.6
cash-flows.row.purchases-of-investments	0	0	-80	-798	-2432.5	-4474	-1006.6	-710	-1020	0	-5	-23	0	44.9	0	0	0	-1.6	0	0	-3.8	-42	-48	-76	-194	-7	-51.7
cash-flows.row.sales-maturities-of-investments	0	400	1131.6	1013.3	2712.2	3146.4	410.1	676.3	903.1	182.4	5	23	0	0.2	0	0	1.8	7.5	0.9	0	87.5	16.3	79.8	118.5	33	41.5	0.2
cash-flows.row.other-investing-activites	0	-51.9	23.5	8	-437	-131	0.1	0	114.6	-178.1	0	-85.2	0.6	-44.7	0.1	0.1	0.8	-4.2	4.3	0.5	-13.2	-7.9	-20.1	-20	0.1	-35.9	-15.5
cash-flows.row.net-cash-used-for-investing-activites	-229.04	178	1009	96.5	-544.5	-1523.6	-665.1	-145.8	-77.3	-57.6	-80.9	-85.1	-44.1	-35.7	-24.4	-9.2	-5.6	2.7	4.1	-0.4	72.5	-29.3	11.7	22.8	-168.3	-1.4	-63.9
cash-flows.row.debt-repayment	-0.1	-0.9	-3.2	-7.1	-0.7	0	0	0	-120	-323.5	-226.4	-327.8	-309.7	-204.5	-120.7	-22.1	-123.8	-122.7	-115.9	-145	-208.3	-445	-494.7	-266.8	-312.8	-335.6	-192.6
cash-flows.row.common-stock-issued	0	0	0	18.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-147.19	-147.2	-11.8	-11	0	-5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-0.02	0	0	-470.3	0	0	0	0	-5	-15.9	-20.5	-24	-8.2	-11.6	-4.6	-1.4	-3.5	-3.8	-2.8	-4.1	-17.3	-30.9	-25.2	-28.7	-36.8	-24.7	-44.3
cash-flows.row.other-financing-activites	-101.59	-160.9	-33.1	-18.1	54.8	0	-194.5	0	1509.9	270.4	288.5	204.2	243.8	225.4	240.5	60.7	84.6	108.2	87.4	3.8	113.4	491.5	476.4	370.4	553	333.3	218.4
cash-flows.row.net-cash-used-provided-by-financing-activities	-100.87	-160.1	-48.1	-488.4	54	-5.5	-194.5	0	1385	-69	41.6	-147.7	-74.1	9.4	115.2	37.1	-42.6	-18.3	-31.3	-145.3	-112.2	15.6	-43.6	74.9	203.4	-27	-18.5
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	-0.2	-0.4	0	0	0	0	0	0	-1	0	0	0	0	0	0	0	0	0	0	0.1	0	-0.5	0	-0.3
cash-flows.row.net-change-in-cash	-214.76	145.8	1122.6	-349.7	336.6	29.6	-479.7	238.8	1570.1	-1.6	97.1	-63.1	-101.7	-43.9	50.5	63.9	8.3	-22.5	-4.7	-10.9	5	-19.6	0.2	29.8	-6.6	24.8	18.4
cash-flows.row.cash-at-end-of-period	11172.23	2729.6	2583.8	1461.2	1811	1474.3	1444.7	1924.4	1685.6	146.2	147.8	50.7	46.6	148.3	192.2	141.7	77.7	69.4	91.9	96.6	107.4	102.4	122	121.8	91.7	110.8	86
cash-flows.row.cash-at-beginning-of-period	11386.99	2583.8	1461.2	1811	1474.3	1444.7	1924.4	1685.6	115.5	147.8	50.7	113.8	148.3	192.2	141.7	77.7	69.4	91.9	96.6	107.4	102.4	122	121.8	92	98.2	86	67.6
cash-flows.row.operating-cash-flow	100.73	127.9	161.7	42.4	827.5	1558.8	379.8	384.6	262.4	124.9	136.5	170.6	16.5	-17.5	-40.3	36	56.5	-6.9	22.6	134.8	44.7	-5.9	32	-68	-41.2	53.2	101
cash-flows.row.capital-expenditure	-166.78	-159.7	-67.6	-126.9	-110.3	-65.1	-68.6	-112	-75	-61.9	-81	-85.2	-44.7	-44.7	-28.1	-10.3	-8.2	-4.2	-1.2	-1	-13.2	-7.9	-20.1	-20	-8.1	-35.9	-15.5
cash-flows.row.free-cash-flow	-66.05	-31.9	94.2	-84.5	717.3	1493.7	311.2	272.6	187.4	63	55.5	85.4	-28.2	-62.2	-68.3	25.7	48.4	-11.1	21.5	133.9	31.5	-13.8	11.9	-88	-49.2	17.3	85.5

Kasumiaruande rida

Dezhan Healthcare Company Limited tulud muutusid võrreldes eelmise perioodiga -0.127%. 000813.SZ brutokasum on teatatud 292.55. Ettevõtte tegevuskulud on 323.01, mille muutus võrreldes eelmise aastaga on -11.270%. Kulud amortisatsioonikulud on 83.67, mis on -0.116% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 323.01, mis näitab -11.270% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 1.690% kasvu võrreldes eelmise aastaga. Tegevustulu on 80.22, mis näitab 1.690% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -1.543%. Eelmise aasta puhaskasum oli 83.31.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	461.1	498.1	570.9	734.5	962.9	1775	3290.8	2220.3	1443	510.8	559.4	569.2	257.3	300.8	296.6	248.9	381.2	338.1	311	358.1	338.6	379.2	372.1	292	463.4	466.6	467.8	412.9	368.9	311.1
income-statement-row.row.cost-of-revenue	196.35	205.5	254.1	242.6	292.5	332.7	242.6	224.6	222.9	333.7	342.6	354.2	225.3	239.3	213.5	219.5	320.1	280	254	289.6	274.4	398.2	318.6	281.1	373.7	313.2	324.9	271.4	230.1	207
income-statement-row.row.gross-profit	264.75	292.6	316.7	491.9	670.4	1442.3	3048.2	1995.7	1220.1	177.1	216.8	215	32	61.4	83.2	29.4	61.1	58	57	68.4	64.2	-19.1	53.5	10.9	89.7	153.4	142.9	141.5	138.8	104.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	50.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	58.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	82.44	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	2.06	1.6	121.9	109.3	105.2	77.3	139.1	115.6	2.3	12	21.4	14.3	17.1	19.6	5.6	1.9	8.1	5.2	4.5	2.4	-0.6	-25.4	1.7	-0.7	1.1	2.6	3	4.3	0.2	-0.1
income-statement-row.row.operating-expenses	322.25	323	364	416.6	428.8	1087.2	2013.6	1064.7	434.5	83.4	81.2	71.5	50.6	58.5	58.3	56.9	45.5	48.3	45.2	49.8	99.5	129.7	39.6	143.7	60.4	66.8	49.2	47.6	48.9	39.6
income-statement-row.row.cost-and-expenses	518.6	528.5	618.1	659.2	721.3	1419.9	2256.2	1289.3	657.4	417	423.8	425.7	275.9	297.8	271.8	276.4	365.6	328.4	299.2	339.5	373.9	527.9	358.2	424.8	434.1	380.1	374.1	318.9	279	246.6
income-statement-row.row.interest-income	69.51	68	67.6	52.7	23.6	6.3	15.3	8.3	1.9	1.3	1.3	1.1	0.5	1.9	1.3	0.9	0.9	1.4	1.1	1.3	1.6	7.8	2.2	1.8	2.7	0	0	0	0	0
income-statement-row.row.interest-expense	0.29	0.4	0.7	0.7	0.2	5.4	1.3	0.5	3.4	14.6	18.4	23.6	7.7	11.6	4.8	1.5	3.5	3.6	2.8	15.3	23.8	30.8	25.3	29.1	33.3	20.9	28.4	33.6	43.5	25.9
income-statement-row.row.selling-and-marketing-expenses	82.44	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	19.19	1.6	-150.9	-192.3	-3.2	7.7	-0.4	1.1	-8.6	-23.9	-39.8	-24.8	5.3	1.9	-18.9	-24.5	-13.2	5.4	-2.6	-15.4	-149.3	-53.9	-9.8	-14.4	-9.5	-7.7	-18.6	-32.9	-43.8	-24.9
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	2.06	1.6	121.9	109.3	105.2	77.3	139.1	115.6	2.3	12	21.4	14.3	17.1	19.6	5.6	1.9	8.1	5.2	4.5	2.4	-0.6	-25.4	1.7	-0.7	1.1	2.6	3	4.3	0.2	-0.1
income-statement-row.row.total-operating-expenses	19.19	1.6	-150.9	-192.3	-3.2	7.7	-0.4	1.1	-8.6	-23.9	-39.8	-24.8	5.3	1.9	-18.9	-24.5	-13.2	5.4	-2.6	-15.4	-149.3	-53.9	-9.8	-14.4	-9.5	-7.7	-18.6	-32.9	-43.8	-24.9
income-statement-row.row.interest-expense	0.29	0.4	0.7	0.7	0.2	5.4	1.3	0.5	3.4	14.6	18.4	23.6	7.7	11.6	4.8	1.5	3.5	3.6	2.8	15.3	23.8	30.8	25.3	29.1	33.3	20.9	28.4	33.6	43.5	25.9
income-statement-row.row.depreciation-and-amortization	61.78	83.7	94.7	84.5	66.9	63.8	46	32.8	20.5	42.6	56.2	45.7	9.6	9.9	9.3	10.2	12.9	14.6	15.9	16.7	17.8	25.5	19	18.8	20.8	21.8	21.1	29.2	41.3	24.6
income-statement-row.row.ebitda-caps	101.53	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	39.75	80.2	29.8	155.2	352.5	380	1053.2	938.8	775.3	58.9	75.4	104.5	-29.3	-14.6	0.7	-51.9	-5.2	12.9	10.1	5.6	-183.3	-180.1	3.5	-143.1	20.1	77.3	72	64.8	48.6	39.9
income-statement-row.row.income-before-tax	58.94	81.8	-121.1	-37.1	349.3	387.8	1052.8	939.9	777	69.9	95.8	118.7	-13.2	4.9	6	-52	2.4	15.1	11.9	5.6	-184.2	-204.1	4.6	-145.5	20.5	79.3	75.1	65.1	47.5	39.7
income-statement-row.row.income-tax-expense	25.12	27.6	32.3	59.1	75.6	52.1	122.3	144.6	117.8	39.8	44.5	41.8	0.5	1	0.5	-1.9	0.3	-0.3	-0.2	1.1	0.7	-0.2	0.6	0	1.6	9.5	7.9	15.2	-43.5	-24.7
income-statement-row.row.net-income	64.65	83.3	-153.4	-96.2	284.5	336.9	930.5	797.2	661.7	6.2	21.5	26.3	-13.6	3.5	6.3	-46.6	2.2	15.5	12.7	9.9	-179.1	-204.4	5.5	-145	19.1	70	67.4	50	48.3	39.7